跳至主要内容
临床试验/CTRI/2022/08/044845
CTRI/2022/08/044845尚未招募不适用

CLINICAL OUTCOMES OF GAMMA KNIFE AND RUTHENIUM PLAQUE BRACHYTHERAPY IN THE TREATMENT OF UVEAL MELANOMA

Dr Rajendra Prasad Centre for Ophthalmic Sciences1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年8月30日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
20
试验地点
1
主要终点
2. Local tumor control-

研究概览

简要总结

Uveal Melanoma is the most common primary malignant intraocular tumor in adults with 80%  of them originating in choroid.This study aims at evaluating the clinical outcomes of two globe salvage therapies that is Stereotactic Radiosurgery using Gamma Knife and Ruthenium Plaque Brachytherapy in the treatment  of Uveal Melanoma.The study design is a prospective interventional study with 20 patients - with 10 of them being subjected to Gamma Knife and 10 of them being subjected to Ruthenium Plaque Brachytherapy. The patients shall be subjected to one of the two treatment modalities and followed up for  a minimum period of 6 months. At each visit, patients will be assessed for all clinical parameters,and investigated through OCT and USG. MRI Orbit will be done at 6 months. Globe Salvage Rate, local tumor control, vision salvage rate , development of local complications, local recurrence of tumor and need for enucleation shall be evaluated.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 85.00 Year(s)(—)
性别
All

入选标准

  • A) CHOROIDAL MELANOMA
  • GAMMA KNIFE
  • Small,medium and large choroidal melanoma according to COMS Classification.
  • Patients giving consent for the study
  • RUTHENIUM PLAQUE BRACHYTHERAPY
  • Small to medium(thickness <7mm ) choroidal melanoma according to COMS Classification.
  • Patients giving consent for the study B) IRIS/CILIARY MELANOMA
  • Patients giving consent for the study 2) RUTHENIUM PLAQUE BRACHYTHERAPY 1.

排除标准

  • A) CHOROIDAL MELANOMA
  • GAMMA KNIFE
  • Tumors with gross extraocular extension
  • Patients with painful blind eye
  • Presenting with metastatic choroidal melanoma
  • RUTHENIUM PLAQUE BRACHYTHERAPY
  • Presenting with metastatic choroidal melanoma B) IRIS/ CILIARY BODY MELANOMA
  • Seeding in anterior chamber
  • Melanomas with secondary glaucoma
  • Scleral/extraocular extension
  • Tapioca/ Ring Melanoma
  • Tapioca/ Ring Melanoma.

结局指标

主要结局

2. Local tumor control-

时间窗: 6 months

%decrease in tumor diameter

时间窗: 6 months

3. Vision salvage rate-assessing post procedure visual outcomes

时间窗: 6 months

5. Need for enucleation

时间窗: 6 months

extension

时间窗: 6 months

1. Globe salvage rate-percentage of cases where enucleation was not required

时间窗: 6 months

and height on USG.

时间窗: 6 months

7. Occurence of Distant

时间窗: 6 months

4. Local recurrence of tumor

时间窗: 6 months

6. Occurence of Extraocular

时间窗: 6 months

metastasis

时间窗: 6 months

次要结局

  • Development of local complications subsequent to therapy:(1. Radiation Retinopathy)

研究者

申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验